In metastatic melanoma
MAKE TREATMENT PERSONAL by testing for the BRAF V600E mutation with the cobas test 速
Test at diagnosis. Test with the cobas 4800 BRAF V600 Mutation Test. 速
Only FDA-approved BRAF PCR diagnostic1 20% more accurate than Sanger Sequencing with fewer false negatives and invalid results1
Indication and Usage: ZELBORAF速 (vemurafenib) is indicated for the treatment of patients with unresectable or metastatic melanoma with BRAFV600E mutation as detected by an FDA-approved test. ZELBORAF is not recommended for use in patients with wild-type BRAF melanoma. Please see Brief Summary of Prescribing Information and next page for Important Safety Information.